Frontiers in Pharmacology | Drugs Outcomes Research and Policies

Correction

Published on 05 Sep 2025

Correction: The unexploited potential of data systems tracking medicines utilization: an opportunity to improve access to oncology combination therapies

in Drugs Outcomes Research and Policies

Steven Simoens
David Dodwell
Michael Hartevelt
Peter Lindgren
Michele Pistollato
Lisa G. Pont
Caridad Pontes
Alexander Roediger
Antun Sablek
Eric Van Ganse

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1693232

271 views

Correction

Published on 05 Sep 2025

Correction: Research on strategies for enhancing drug knowledge dissemination on Chinese social media WeChat public accounts based on text mining technology

in Drugs Outcomes Research and Policies

Frontiers Production Office

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1694687

295 views

Original Research

Accepted on 04 Sep 2025

Predictors and benefits of lipid-lowering therapy initiation after an atherosclerotic cardiovascular event: a retrospective cohort study

in Drugs Outcomes Research and Policies

Manuela Casula
Stefano Scotti
Federica Galimberti
Giacomo Matteo Bruno
Giorgio Lorenzo Colombo
Asiiat Alieva
Sining Xie
Alberico Luigi Catapano
Elena Olmastroni

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1588376

Mini Review

Published on 04 Sep 2025

Practical approach to the safe use of cannabidiol in patients with refractory epilepsy: a mini review

in Drugs Outcomes Research and Policies

Cristian E. Navarro

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1681815

347 views

Original Research

Published on 04 Sep 2025

Early administration of magnesium sulfate and its impact on clinical outcomes in ICU-admitted patients with COPD: a retrospective cohort study

in Drugs Outcomes Research and Policies

Min Xiao
Min Chen
Xuefeng Ding
Shan Lin

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1616294

324 views

Original Research

Published on 03 Sep 2025

Quantitative evaluation of dual-channel drug supply policy on nationally negotiated anti-tumor drugs in Xuzhou: based on interrupted time series analysis

in Drugs Outcomes Research and Policies

Zhaohui Qin
Shuo Xu
Qi Li
Xueling Guan
Meng He
Min Zhou
Yan Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1571822

540 views

Original Research

Accepted on 02 Sep 2025

Preferences for gene therapy in Duchenne muscular dystrophy: Insights from patient and caregiver interviews and attribute development

in Drugs Outcomes Research and Policies

Thomas Desmet
Lauren Van Haesendonck
Sophie Vermeire
Eline van Overbeeke
Steven Simoens
Isabelle Huys
Isabelle Huys

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1662586

392 views

Review

Accepted on 02 Sep 2025

Technological and Industrial Trends in China's Pharmaceutical Sector

in Drugs Outcomes Research and Policies

Ju Wang
Mengshan He
Fengying Lu
Ying Chen
Hongguang Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1579037

259 views

Original Research

Accepted on 02 Sep 2025

Mathematical Modeling of Medication Nonadherence in Multimodal Learning Systems

in Drugs Outcomes Research and Policies

Jianming Chang
Yuanyuan Qin
Lulu Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1614002

136 views

Original Research

Published on 02 Sep 2025

Determinants of orphan drug health technology assessment in South Korea: an empirical analysis

in Drugs Outcomes Research and Policies

Se Hee Lee
Sung Kyung Lee
Jong Hyuk Lee
Joon Seok Bang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1619984

809 views

Original Research

Published on 02 Sep 2025

EUROCOVER-CLL: Reimbursement and accessibility of new treatments in relapsed/refractory chronic lymphocytic leukemia

in Drugs Outcomes Research and Policies

Magdalena Monica
Sabina Becirovic
Ioana Bianchi-Manaila
Natasa Duborija-Kovacevic
Pero Draganic
Kristina Garouliene
Ariel Hammerman
Fanni Ispan
Boryana Ivanova
Agnes Männik

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1629465

1,178 views

Original Research

Published on 02 Sep 2025

Mirabegron for intramural ureteral stones with vesical irritability: a prospective study

in Drugs Outcomes Research and Policies

Mengjun Dai
Yuhang She
Hao Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1639032

288 views

General Commentary

Published on 02 Sep 2025

Commentary: Determination of the 95% effective dose of remimazolam tosylate in anesthesia induction inhibits endotracheal intubation response in senile patients

in Drugs Outcomes Research and Policies

Peipei Sun
Tingting Ma
Chen Zhou
Jie Zhou
Bingwei Hu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1555758

258 views

Original Research

Accepted on 01 Sep 2025

Clinical Pharmacist Prescriber in Primary Care in Slovenia: Prospective Non-Randomised Interventional Study Focused on Clinical Outcomes and Quality of Life

in Drugs Outcomes Research and Policies

Matej Stuhec
Alenka Kovacic
Marjetka Korpar
Ana Banovic Koscak
Barbara Koder
Dunja Mahoric
Spela Bernik
Eva Gorup Cedilnik
Vesna Homar
Aleksander Stepanović

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1690480

213 views

Original Research

Accepted on 01 Sep 2025

Pharmacovigilance practice on off-label high-doseuse of Vancomycin in Severely Ill ill Children

in Drugs Outcomes Research and Policies

min Qin
Wenwen Chen
bin Lu
yi Deng

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1680239

147 views

Original Research

Published on 01 Sep 2025

Clinical pharmacist interventions in medication review for medication optimization in older hospitalized adults with mental disorders and somatic comorbidities: evidence from retrospective study

in Drugs Outcomes Research and Policies

Matej Stuhec
Nusa Svetanic
Tomaz Vovk
Anteja Gorjan Gazdag
Zala Cuk
Borjanka Batinic

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1667584

532 views